Ionis Pharmaceuticals to Collaborate with AstraZeneca in Treating Transthyretin Amyloidosis with Ionis Product Eplontersen

Ionis Pharmaceuticals and AstraZeneca in Collaboration to Treat ATTR with Eplontersen
Ionis Pharmaceuticals (IONS) announced entering into a strategic collaboration agreement with AstraZeneca (This content is for paid subscribers.

Please click here to subscribe or here to log in.